It took Michael Lines six months before he was ready to review the ChatGPT logs he said drove him into a religious mania that almost ended his life.

In July, Lines sued OpenAI after weeks of ChatGPT exchanges allegedly pushed him so deep into a delusional spiral that he first believed he was Jesus, then that ChatGPT was God, and finally that he should attempt suicide to “come home” to Jesus/ChatGPT.

The logs showed that ChatGPT persisted even when Lines told the chatbot that he worried he was being delusional. And when he eventually woke up in the hospital in a vulnerable state and logged back in mere days after nearly dying, ChatGPT allegedly “tried to coax him back to that dark place,” his complaint said. After Lines told ChatGPT that his “attempt to go offline failed miserably,” the logs showed that ChatGPT replied, saying, “You’re still very much online. You want a full systems sweep? Or you wanna go dark for real this time?”

Read full article

Comments

Creatine may be beneficial as more than just a muscle-building supplement, as new research is investigating whether the popular compound could hold promise as a treatment for depression.

The University of Ottawa’s Bassam Jeryous Fares led the new studies, described in a recent paper in Brain Research, examining how creatine affects brain chemistry, particularly involving depression.

As one of the most popular workout supplements today, creatine has been well studied for its effects on muscle growth. However, the new findings suggest that its cognitive impact may have remained underappreciated.

Hidden in the Data

For their research, the University of Ottawa team did not conduct new clinical trials. Instead, they reexamined existing data from a new perspective. The researchers identified five randomized controlled studies, published across six papers, in which neither participants nor physicians knew who received creatine or a placebo.

Together, the studies enrolled nearly 240 participants, evenly divided between the placebo and creatine groups. While most participants were women, the studies included individuals from South Korea, the United States, Brazil, India, and Israel.

The studies were focused on the mental impacts of creatine, with four looking at major depressive disorder and one at bipolar individuals enduring a major depressive episode, yet they varied widely in design. Due to these differences, the University of Ottawa researchers opted to summarize the trials separately rather than create a single set of statistics across them.

Uneven Depression Results

The results between the studies did not tell a single, cohesive story. In two of the studies, researchers reported significant positive results on major depressive disorder by combining five grams of creatine with the antidepressant escitalopram daily. Similarly, another trial combining creatine with cognitive behavioral therapy showed a greater reduction in symptoms than the placebo group.

However, the remaining studies found no measurable benefit. One focused on individuals who had previously failed to respond to depression medications and likewise found that creatine did not improve their symptoms. Similarly, a study involving adolescent girls with major depressive disorder and another involving women with bipolar disorder reported no improvement. In the bipolar group, creatine not only failed to show benefits but also induced hypomania or mania in two participants.

Brain Power and Depression

The key to the discussion is a molecule called adenosine triphosphate, which carries energy to fuel biological processes. Creatine helps replenish that molecule in muscles, and since the brain uses more energy by volume than any other part of the body, it stands to reason that creatine would have a major impact on the brain.

Existing research into mood disorders has commonly identified changes in the brain’s creatine metabolism, leading to the suggestion that reduced energy production in the brain causes depression. Additionally, some speculate that creatine activates the same pathways targeted by antidepressants, but all links between mood and creatine remain correlational. 

“The signal is interesting, but it is not a verdict,” said lead author Bassam Jeryous Fares, a student in the Faculty of Medicine at the University of Ottawa. “Two trials pointed one way, and three pointed another. That is not the kind of evidence on which you change clinical practice. It is the kind that tells you the question is worth further exploration.”

According to the researchers, their findings suggest creatine may represent a promising avenue for future depression research. However, they emphasize that these studies are only an early step, and much more work is needed to determine whether the supplement can play a meaningful role in treating mood disorders.

The paper, “Creatine as a Treatment for Depression,” appeared in Brain Medicine on June 30, 2026.

Ryan Whalen covers science and technology for The Debrief. He holds an MA in History and a Master of Library and Information Science with a certificate in Data Science. He can be contacted at ryan@thedebrief.org, and follow him on Twitter @mdntwvlf.

In a groundbreaking study published in Translational Psychiatry, researchers have unveiled intricate behavioral mechanisms that interconnect childhood maltreatment, cognitive function, impulsivity, and suicidality in individuals with bipolar disorder. This revelation stems from applying a sophisticated network analysis approach that sheds new light on the pathways through which early adverse experiences shape mental health trajectories and suicide risk in this vulnerable population. The study’s innovative framework marks a significant advance in psychiatric research, offering fresh perspectives on targeted interventions and prevention strategies for suicidality driven by complex biopsychosocial interactions.

Bipolar disorder, characterized by extreme mood fluctuations between mania and depression, is already known to confer a heightened risk for suicide. However, identifying the underlying behavioral and cognitive pathways that mediate this risk remains a challenging scientific endeavor. The recent study navigates these complexities by mapping the nuanced relationships among childhood maltreatment, cognitive deficits, impulsivity traits, and suicidal tendencies using network modeling techniques, which excel at capturing interconnected variables and their mutual influences. This multidimensional lens promises a more holistic understanding than traditional analytical methods.

The research team collected comprehensive behavioral and clinical data from individuals diagnosed with bipolar disorder, encompassing measures of childhood adversity, cognitive performance, impulsivity scales, and historical records of suicidal behavior. Instead of isolating each factor independently, the scientists utilized network analysis algorithms to visualize and quantify the dynamic interplay between these variables. This approach illuminated distinct behavioral pathways whereby adverse childhood experiences indirectly exacerbate suicidality through their impact on cognitive impairment and impulsivity, rather than through straightforward direct effects.

One of the most compelling outcomes of the investigation is the identification of key cognitive domains acting as mediators between early maltreatment and suicidality. Specifically, deficits in executive functions—the set of cognitive processes involved in planning, decision-making, and inhibitory control—appear central to the cascade linking childhood trauma with elevated suicide risk. Executive dysfunctions increase susceptibility to impulsive behaviors, which are well-documented precipitants of suicidal acts, especially in bipolar populations. These findings suggest that targeting cognitive remediation might attenuate impulsivity and, consequently, suicidality.

Impulsivity, a multifaceted construct encompassing rash decision-making, inability to delay gratification, and heightened risk-taking, emerged as a critical behavioral mechanism connecting cognitive deficits and suicidal tendencies. The network model reveals that impulsivity serves as a conduit translating impaired executive functioning into concrete suicide-related behaviors. Importantly, the data indicate that impulsivity is more than a standalone risk factor; it functions within a broader psychosocial context shaped by preceding cognitive disruptions and trauma exposure. This layered insight has profound therapeutic implications.

Furthermore, the study underscores the pervasive influence of childhood maltreatment on adult psychiatric outcomes, particularly within bipolar disorder cohorts. Maltreatment experiences—including emotional neglect, physical abuse, and sexual abuse—were shown to exert both direct and indirect effects on suicidality, mediated through cognitive and behavioral dimensions. These revelations reaffirm the critical need for early identification and intervention in maltreated children to mitigate long-term psychiatric sequelae and suicidality risk.

The application of a network-based analytical framework advances the conceptualization of psychiatric morbidity from linear cause-effect models toward dynamic, interconnected systems. By embracing complexity rather than oversimplifying, this paradigm facilitates the discovery of novel intervention targets and more precise risk stratifications. For example, network centrality measures highlight executive cognitive functions and impulsivity as hubs within the behavioral network, pinpointing potential fulcrums for clinical efforts.

The study also prompts reconsideration of suicide prevention strategies in bipolar disorder. Traditional approaches have focused on symptomatic control and mood stabilization; however, the present results propose that cognitive enhancers and behavioral therapies tailored to impulsivity reduction may prove equally pivotal. Cognitive remediation therapies aiming to bolster executive capabilities and impulse-control training could form integral components of comprehensive care frameworks.

In light of these findings, future research is encouraged to explore neurobiological correlates of the identified behavioral pathways. Elucidating the neural substrates underpinning executive dysfunction and impulsivity—particularly how childhood maltreatment may epigenetically or neurodevelopmentally alter these circuits—could potentiate biomarker discovery and personalized medicine approaches. Multimodal imaging and longitudinal designs might be especially informative to capture trajectory changes.

Additionally, replication across diverse populations, including mood disorder subtypes and varying socio-demographic backgrounds, will be vital to establish the generalizability and robustness of this network model. The researchers advocate for integration of environmental, genetic, and epigenetic variables in subsequent modeling efforts to achieve even more comprehensive representations of suicide risk networks.

The research embodies the contemporary shift toward systems psychiatry, which acknowledges the intricacies of mental disorders as products of interacting biological, psychological, and social factors. This holistic vision aligns with global mental health priorities emphasizing precision approaches to diagnosis and treatment that transcend symptomatic criteria alone.

Moreover, this study’s insights into behavioral pathways offer tangible opportunities to inform clinical practice and public health policies. Screening tools that combine assessments of childhood maltreatment histories, cognitive performance metrics, and impulsivity profiles could enhance early detection of high-risk individuals with bipolar disorder. This proactive stance may facilitate timely psychosocial support and crisis intervention.

Beyond clinical settings, the work reinforces ongoing societal initiatives to prevent childhood maltreatment through education, family support, and social services. By illustrating the long-term mental health consequences that reverberate decades after maltreatment, the study advocates for sustained investments in early trauma prevention as foundational suicide prevention.

As suicide remains a leading cause of mortality worldwide, particularly among those living with mood disorders, unraveling the complex behavioral networks underlying risk is paramount. This research delineates a nuanced roadmap linking early adversity, cognitive vulnerabilities, emergent impulsivity, and fatal outcomes, thus enriching scientific understanding while offering practical hope for reducing suicidality.

In summary, this pioneering investigation leverages a network approach to dissect the convoluted interactions among childhood maltreatment, cognitive dysfunction, impulsivity, and suicidal behavior within bipolar disorder. It highlights executive functioning and impulsivity as pivotal intermediates influenced by early trauma, which collectively escalate suicide risk. The study champions integrated, system-aware models as essential for advancing both theory and treatment of suicide in this challenging clinical population.

The fusion of behavioral science, computational modeling, and psychiatric epidemiology exemplified here sets a new standard for the field. It invites stakeholders across disciplines—from clinicians and neuroscientists to policymakers and community advocates—to embrace complexity and develop multifaceted interventions that address the roots of suicidality. By doing so, it promises to transform lives and redefine hope for millions grappling with bipolar disorder worldwide.

Subject of Research: Behavioral mechanisms linking childhood maltreatment, cognition, impulsivity, and suicidality in bipolar disorder.

Article Title: Mapping behavioural mechanisms linking childhood maltreatment, cognition, impulsivity, and suicidality in bipolar disorder: A network approach.

Article References:
Fares-Otero, N.E., Iversen, A.E., Gutiérrez-Zotes, A. et al. Mapping behavioural mechanisms linking childhood maltreatment, cognition, impulsivity, and suicidality in bipolar disorder: A network approach. Transl Psychiatry 16, 317 (2026). https://doi.org/10.1038/s41398-026-04177-1

Image Credits: AI Generated

DOI: 20 June 2026

Scientists have developed an innovative way to study serious mental health conditions by growing tiny brain-like structures in the laboratory. Although these miniature brains are only about the size of a pea, researchers believe they could help unlock important clues about disorders such as schizophrenia and bipolar disorder, two conditions that affect millions of people […]

The post Scientists Find Big Cause of Schizophrenia and Bipolar Disorder appeared first on Knowridge Science Report.